1346263-87-3

Upstream product

• 3943-74-6 4-hydroxy-3-methoxybenzoic acid methyl ester 
• 14267-92-6 1-chloro-4-pentyne 

Downstream Products

• 1346263-89-5 4-[3-(1-butyl-1H-1,2,3-triazol-4-yl)propoxy]-N-[4-[(indan-2-yl)(propyl)amino]butyl]-3-methoxybenzamide 
• 1346263-90-8 4-[3-(1-butyl-1H-1,2,3-triazol-4-yl)propoxy]-3-methoxy-N-[4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl]benzamide 
• 1346263-92-0 N-[4-[(indan-2-yl)(propyl)amino]butyl]-3-methoxy-4-[3-[1-[8-[4-[3-[2-methoxy-4-[[4-(2-methoxyphenyl)piperazin-1-yl]methyl]phenoxy]propyl]-1H-1,2,3-triazol-1-yl]octyl]-1H-1,2,3-triazol-4-yl]propoxy]benzamide 
• 1346263-86-2 4,4'-[octan-1,8-diylbis(1H-1,2,3-triazol-1,4-diylpropan-3,1-diyloxy)]bis[3-methoxy-[N-[4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl]benzamide]] 
• 1346263-95-3 3-methoxy-4-(pent-4-yn-1-yloxy)benzoic acid 
• 1346263-96-4 N-[4-[(indan-2-yl)(propyl)amino]butyl]-3-methoxy-4-(pent-4-yn-1-yloxy)benzamide 
• 1346263-97-5 3-methoxy-N-[4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl]-4-(pent-4-yn-1-yloxy)benzamide 
• 1346263-98-6 4-[3-[1-(8-azidooctyl)-1H-1,2,3-triazol-4-yl]propoxy]-N-[4-[(indan-2-yl)(propyl)amino]butyl]-3-methoxybenzamide 
• 1346263-91-9 4-[3-[1-[8-[4-[3-[4-[[[4-[(indan-2-yl)(propyl)amino]butyl]amino]carbonyl]-2-methoxyphenoxy]propyl]-1H-1,2,3-triazol-1-yl]octyl]-1H-1,2,3-triazol-4-yl]propoxy]-3-methoxy-N-[4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl]benzamide 
• 1346263-93-1 methyl 4-[3-(1-butyl-1H-1,2,3-triazol-4-yl)propoxy]-3-methoxybenzoate 
• 1346263-88-4 4,4'-[octane-1,8-diylbis(1H-1,2,3-triazol-1,4-diylpropan-3,1-diyloxy)]bis(3-methoxybenzoic acid) 

Relevant academic research and scientific papers

Development of a bivalent dopamine D2 receptor agonist

Bivalent D2 agonists may function as useful molecular probes for the discovery of novel neurological therapeutics. On the basis of our recently developed bivalent dopamine D2 receptor antagonists of type 1, the bivalent agonist 2 was